Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Analysis summary4-Traders Strategies

Anaïs Lozach

Analyst
 
share with twitter share with LinkedIn share with facebook
share via e-mail

A support level that should be taken advantage of

Strategy published on 08/14/2017 | 09:27
long trade
Stop-loss triggered
Entry price : 81.01€ | Target : 88.7€ | Stop-loss : 77.9€ | Potential : 9.49%
The selling pressure regarding Sanofi shares could subside shortly. In fact, the support area that is currently being tested around 79.69 EUR has come into play and could, at least in the short term, keep the downside pressure at bay.
Investors have an opportunity to buy the stock and target the € 88.7.
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.

Strengths
  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at EUR 78.51 EUR in weekly data.
  • Graphically speaking, the timing seems perfect for purchasing the stock close to the EUR 79.69 support.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • The company is in a robust financial situation considering its net cash and margin position.
  • The company's attractive earnings multiples are brought to light by a P/E ratio at 13.09 for the current year.
  • This company will be of major interest to investors in search of a high dividend stock.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 78.51 EUR

Weaknesses
  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (€)
Sales 2017 35 834 M
EBIT 2017 9 337 M
Net income 2017 8 158 M
Debt 2017 4 979 M
Yield 2017 4,05%
P/E ratio 2017 11,69
P/E ratio 2018 16,21
EV / Sales 2017 2,77x
EV / Sales 2018 2,72x
Capitalization 94 306 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart SANOFI
Duration : Period : Day
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Duration : Period : Week
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders